全球基因增殖技术行业研究报告——Gene Amplification Gene amplification technology industry research report -- Gene Amplification.doc

窗体顶端全球基因增殖技术行业研究报告Gene Amplification Technologies - A Global Strategic Business Report联系购买电话公司名称：佐思信息 公司地址：北京市海淀区苏州街18号院长远天地大厦A2座 1008-1室（100080） 2011.1摘要This report analyzes the worldwide markets for Gene Amplification Technologies in US$ Million by the following Product segments: Polymerase Chain Reaction, and Other Gene Amplification Technologies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets.The report profiles 91 companies including many key and niche players such as Abbott Laboratories, Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, Cepheid, Life Technologies Corp., QIAGEN N.V, Roche Diagnostics, Rubicon Genomics, and Takara Bio, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.目录GENE AMPLIFICATION TECHNOLOGIES (Complete Report)Pages : 466 |$4500 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.1 Study Reliability and Reporting Limitations.1 Disclaimers.2Data Interpretation & Reporting Level.2 Quantitative Techniques & Analytics.3Product Definitions and Scope of Study.3Definitions.3Polymerase Chain Reaction.3Other Gene Amplification Technologies.3 2. INDUSTRY OVERVIEW.II-4 PCR Dominates Amplification Technologies.II-4Miniaturization The Next Big Focus.II-4 Critical in Diagnostic Procedures.II-5Leading Players.II-53. TECHNOLOGY OVERVIEW.II-6 Definition of Gene Amplification.II-6Target vs. Signal Amplification.II-6Available Types of Gene Amplification Technologies.II-6Polymerase Chain Reaction.II-6 Reagents and Equipment required for PCR.II-7Reaction Steps.II-7Denaturation.II-7Annealing.II-7Extension.II-7 Detection of Amplified Product/DNA.II-8(Q&Q) PCR.II-8 Reverse Transcriptase PCR (RT-PCR). II-9Alternative Technologies to PCR.II-9OmniPlex.II-9 Strand Displacement Amplification.II-10Ligase Chain Reaction.II-10LCR Involves a Cyclic Two-Step Reaction.II-10Gene Amplification Technology (GAT).II-10Hybrid Capture.II-10 Isothermal DNA Amplification Techniques.II-11Rolling circle Amplification in Diagnostics.II-11Ican Isothermal Gene Amplification Technology.II-11BioHelix HDA Technology.II-11Other Amplification Technologies.II-11Signal Amplification Technology.II-11 Transcription Mediated Amplification.II-12DNA cleavage-based signal amplification.II-12Ramification Amplification Method.II-124. END USE MARKET ANALYSIS.II-13 Medical and Diagnostics.II-13Role of Amplification Technology in the Diagnoses of Infectious Diseases.II-13Diagnosis of Infectious Diseases by PCR.II-13 Detection of Antimicrobial Resistance.II-14PCR Based Nucleic Acid Amplification for Detection of Antimicrobial Agents.II-14Nucleic Acid Amplification Testing (NAT).II-14 Nucleic Acid Amplification Methods.II-15DNA Amplification Technology in the Diagnosis of Infectious Diseases.II-15Forensic and Paternity Testing.II-15 Food Safety.II-165. PRODUCT INNOVATIONS/LAUNCHES.II-17 DuPont Qualicon Launches New BAXSystem Real-Time PCR Assay.II-17Rubicon Genomics Launches PicoPlex Single Cell WGA Kit.II-17NuGEN Unveils WT-OvationTM RNA Amplification System for Whole-Transcriptome Gene  Expression Analysis.II-17 DuPont Qualicon Obtains Approval from Russian Federal Consumer Rights Protection and  Human Health Control Service for BAXSystem.II-18DuPont Qualicon Receives Approval from the General Administration of Quality  Supervision, Inspection and Quarantine for BAXsystem.II-18 Seegene Enters into Partnership with Shimadzu.II-19Bio-Rad Launches New CFX96 PCR Detection System.II-196. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST A PERSPECTIVE BUILDER.II-20 Roche Introduces Genome Sequencer FLX System.II-20QIAGEN Launches TopTaq DNA Polymerase.II-20Applied Biosystems Introduces TaqMan Array Human MicroRNA Panel.II-20 Spartan Introduces Spartan DX.II-21Applied Biosystems Launches Forensic Tools.II-21Applied Biosystems Introduces StepOne Real-Time PCR System.II-21 Sigma-Aldrich Unveils GenomePlex Tissue Whole Genome Amplification Kit.II-22QIAGEN Rolls Out Wide RNAi and SYBR Green-based RT- PCR.II-22Applied Biosystems Launches 7500 Fast Real-Time PCR System.II-22 Applied Biosystems Launches 9800 Fast PCR System.II-237900HT Fast Real-Time PCR System from Applied Biosystems.II-23Enzo Life Sciences Introduces New Advanced Amplification Technology.II-23 Applied Biosystems Unveils AmpFSTRYfilerPCR Amplification Kit.II-24Amersham Launches GenomiPhi.II-24Rubicon Genomics Launches GenomePlex WGA.II-24Agilent Introduces Amplification Kit.II-24 Linden Introduces Snapshot mRNA.II-25Rubicon Launches OmniPlex.II-257. RECENT INDUSTRY ACTIVITY.II-26 QIAGEN Acquires Rights to 70 Molecular Food Safety Tests from ifp.II-26Life Technologies to Acquire Geneart.II-26Thermo Fisher Scientific Takes Over Finnzymes.II-26Abbott Inks Agreement with GlaxoSmithKline for Developing Molecular Diagnostic  Test.II-26 DXS Purchases License for P13K Gene from Johns Hopkins University.II-27Qiagen Acquires SABiosciences.II-27DuPont Qualicon Obtains License from DxS for Scorpions Technology.II-27 BD Takes Over HandyLab.II-28Life Technologies Takes Over BioTrove.II-28Merck Merges with Schering-Plough.II-28QIAGEN Acquires Licenses from Idaho Technology and Roche.II-28 Response Genetics Inks Non-Exclusive Agreement with Roche Diagnostics.II-29Invitrogen Announces Merger with Applied Biosystems.II-29Hologic Acquires Third Wave Technologies.II-29BIOTECON Acquires Roches Technology License.II-29 QIAGEN Signs a Global Licensing Agreement with BioHelix.II-30BioTrove and Gene Express Receive NIH Grant for Innovative Bio-experimentation.II-308. CORPORATE ACTIVITY IN THE RECENT PAST A PERSPECTIVE BUILDER.II-31 SuperArray Bioscience Inks License Agreement with Applied Biosystems.II-31Merck Capital Takes Over Minority Interest in High Throughput Genomics.II-31NuGEN Enters into a Service Agreement with ExonHit.II-31 Qiagen Enters into License Agreements with Roche and Ortho-Clinical.II-32Agilent Takes Over Stratagene.II-32Eiken Chemical Inks Licensing Agreement with Meridian Bioscience.II-32 Sigma-Aldrich Acquires JRH.II-33Sigma-Aldrich Snaps Up Proligo.II-33Beckman Acquires Agencourt.II-33Roche Diagnostics and Applera Corporation Expand PCR Licensing Program.II-33Mount and Hamilton Receive Patent.II-33Invitrogen Bags License from Applied Biosystems.II-33 OriGene to Access TrueClone.II-34Orchid BioSciences to Turn into Orchid Cellmark.II-34QIAGEN Purchases Assets of Molecular Staging.II-34Cepheid, Applied Biosystems and Celera Diagnostics Sign Patent License  Agreement.II-34 Abbott Enters into Agreement with BioGenex.II-35Roche Inks Licensing Agreement with Incyte Corp.II-35Rubicon Genomics Signs Licensing Agreement with Sigma-Aldrich.II-35BioM閞ieux Teams-up with Cepheid.II-35Molecular Staging Collaborates with Eli Lilly.II-35Pacific Biometrics Inc. Receives Gene Amplification Patent.II-35 Rubicon Introduces Service for Genome Amplification.II-36Takara Obtains Patent for New Amplification Method.II-369. FOCUS ON SELECT GLOBAL PLAYERS.II-37 Abbott Laboratories (US).II-37Becton, Dickinson and Company (US).II-37bioM閞ieux (France).II-37 Bio-Rad Laboratories (US).II-38Cepheid (US).II-38Life Technologies Corp. (US).II-38 QIAGEN N.V. (The Netherlands).II-39Roche Diagnostics (Switzerland).II-39 Rubicon Genomics (US).II-40Takara Bio, Inc.II-4010. GLOBAL MARKET PERSPECTIVE.II-41 Table 1: World Recent Past, Current & Future Market Analysis for Gene Amplification Technologies by Geographic Region US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-41 Table 2: World Historic Review for Gene Amplification Technologies by Geographic Region US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-42 Table 3: World 11-Year Perspective for Gene Amplification Technologies by Geographic Region Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).II-43 Table 4: World Recent Past, Current & Future Market Analysis for Polymerase Chain Reaction (PCR) by Geographic Region US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-44 Table 5: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-45 Table 6: World 11-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).II-46 Table 7: World Recent Past, Current & Future Market Analysis for Other Gene Amplification Technologies by Geographic Region US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-47 Table 8: World Historic Review for Other Gene Amplification Technologies by Geographic Region US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-48 Table 9: World 11-Year Perspective for Other Gene Amplification Technologies by Geographic Region Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).II-4911. THE UNITED STATES.II-50 A. Market Analysis.II-50Real-Time PCR Market in North America: A Primer.II-50 Table 10: Leading Suppliers of Individual qPCR Reagents in North America (2008): Percentage Dollar Share Breakdown of Invitrogen, Applied Biosystems, Roche Applied, Bio-Rad/ MJ, BD Clontech, Promega, Amblon, NEB, Qiagen, and Others (includes corresponding Graph/Chart).II-50 Key Factors (Ranked in Order) in Selection of Real-Time/qPCR Platforms  Manufacturers.II-51Top 10 Research Applications of Real-Time Quantitative PCR (qPCR) in North  America.II-51 B. Market Analytics.II-52 Table 11: US Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-52 Table 12: US Historic Review for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-53 Table 13: US 11-Year Perspective for Gene Amplification Technologies by Segment Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2005, 2010 & 2015.II-5312. CANADA.II-54 Market Analysis.II-54 Table 14: Canadian Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-54 Table 15: Canadian Historic Review for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-55 Table 16: Canadian 11-Year Perspective for Gene Amplification Technologies by Segment Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2005, 2010 & 2015.II-5513. JAPAN.II-56 Market Analysis.II-56 Table 17: Japanese Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-56 Table 18: Japanese Historic Review for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-57 Table 19: Japanese 11-Year Perspective for Gene Amplification Technologies by Segment Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2005, 2010 & 2015.II-5714. EUROPE.II-58 Market Analysis.II-58 Table 20: European Recent Past, Current & Future Analysis for Gene Amplification Technologies by Geographic Region France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-58 Table 21: European Historic Review for Gene Amplification Technologies by Geographic Region France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-59 Table 22: European 11-Year Perspective for Gene Amplification Technologies by Geographic Region Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, & Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).II-60 Table 23: European Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-61 Table 24: European Historic Review for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-62 Table 25: European 11-Year Perspective for Gene Amplification Technologies by Segment Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2005, 2010 & 2015.II-62 14a. FRANCE.II-63 Market Analysis.II-63 Table 26: French Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-63 Table 27: French Historic Review for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).II-64 Table 28: French 11-Year Perspective for Gene Amplification Technologies by Segment Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2005, 2010 & 2015.II-64 14b. GERMANY.II-65 Market Analysis.II-65 Table 29: German Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).II-65 Table 30: German Historic Review for Gene Amplification Technologies by Segment Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual